October 26, 2018 — In a recent speech about drug pricing, President Trump described current problems impacting the issue, including the lack of a mechanism to lower prices in Medicare Part B. However, the administration did not outline clear solutions. In fact, as CP3 Director Walid Gellad writes in STAT, Read More »